US stock · US markets · public data

ABT

Abbott Laboratories · Healthcare

Reference price$102.97Updated according to the public source
P/E33.22
P/B3.49
ROE10.58%
DY 12M2.41%
Net margin—
Net debt/equity—
Market capUS$ 178.2 B
Volume (shares)7,258,980
SectorHealthcare
Overview

About ABT

Demonstrações públicas consolidadas + SEC Company Facts

Abbott Laboratories (ABT) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data
06/18
09/18
03/19
03/20
09/23
03/24
06/24
09/24
03/25
06/25
09/25
03/26
Income in shown records$5.80
DY 12M2.41%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-03-31Dividendo declarado$0.63
Period ending 2025-09-30Dividendo declarado$0.59
Period ending 2025-06-30Dividendo declarado$0.59
Period ending 2025-03-31Dividendo declarado$0.59
Period ending 2024-09-30Dividendo declarado$0.55
Period ending 2024-06-30Dividendo declarado$0.55

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$40,109,000,000.00$41,950,000,000.00$44,328,000,000.00—
Operating Income$6,478,000,000.00$6,825,000,000.00$8,053,000,000.00—
Net Income$5,723,000,000.00$13,402,000,000.00$6,524,000,000.00—
EPS Diluted$3.26 / share$7.64 / share$3.72 / share—

Balance sheet

Account2023202420252026
Total Assets$73,214,000,000.00$81,414,000,000.00$86,713,000,000.00—
Total Equity$38,827,000,000.00$47,901,000,000.00$52,771,000,000.00—
Long-term Debt$13,599,000,000.00$12,625,000,000.00$9,896,000,000.00—
Current Debt$1,080,000,000.00$1,500,000,000.00$3,033,000,000.00—
Shares Outstanding1,737,946,233 shares1,735,184,289 shares1,734,323,411 shares1,737,682,887 shares
Cash & Investments$8,078,000,000.00$8,853,000,000.00$9,857,000,000.00—
Dívida Líquida$6,601,000,000.00$5,272,000,000.00$3,072,000,000.00—

Cash flow

Account2023202420252026
Operating Cash Flow$7,261,000,000.00$8,558,000,000.00$9,566,000,000.00—
Capital Expenditures$2,202,000,000.00$2,207,000,000.00$2,171,000,000.00—
Dividends Paid$3,556,000,000.00$3,836,000,000.00$4,116,000,000.00—
Free Cash Flow$5,059,000,000.00$6,351,000,000.00$7,395,000,000.00—
FAQ

Frequently asked questions

What is the price of ABT?

The reference price available for ABT is $102.97.

What is the P/E of ABT?

The P/E ratio of ABT is 33.22. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of ABT?

The P/B of ABT is 3.49. This compares price with reported book value per share.

What is the ROE of ABT?

The ROE (Return on Equity) of ABT is 10.58%. This relates the reported net result to shareholders' equity.

What is the dividend yield of ABT?

The dividend yield of ABT is 2.41%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of ABT?

The market capitalization of ABT is US$ 178.2 B.

What sector is ABT in?

ABT operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.